Biografisk notat

Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. He earned his Ph.D. in Pharmaceutical Sciences in 2013 and has over 20 years of academic experience. Dr. Kapoor has published 175+ research and review articles and contributed 50 book chapters. He is currently editing 18 international books with leading publishers and supervises four Ph.D. students in nanodrug delivery and modified release systems. His editorial roles include Associate Editor for Naunyn-Schmiedeberg’s Archives of Pharmacology, PLOS ONE, and several Frontiers journals, and Consulting Editor for Cytotechnology. He has reviewed manuscripts for 135+ journals and holds eight design patents. Dr. Kapoor has secured research and event grants from GUJCOST, GSBTM, and AICTE-ATAL, delivered 20+ invited talks, and actively participates in national conferences and workshops. . Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals. Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.